{
    "clinical_study": {
        "@rank": "57194", 
        "acronym": "Nifedipine", 
        "arm_group": [
            {
                "arm_group_label": "Nifedipine", 
                "arm_group_type": "Experimental", 
                "description": "Women with preterm labor will receive nifedipine."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Experimental", 
                "description": "Women with preterm labor will receive placebo."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if nifedipine treatment of women in preterm labor\n      receiving corticosteroids results in postponement of delivery when compared to placebo."
        }, 
        "brief_title": "Nifedipine for Acute Tocolysis of Preterm Labor", 
        "condition": "Preterm Labor", 
        "condition_browse": {
            "mesh_term": "Obstetric Labor, Premature"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Between 18 and 44 years of age inclusive\n\n          -  Singleton pregnancy\n\n          -  Intact membranes\n\n          -  Between 28-0/7 weeks and 33-6/7 weeks' gestation inclusive\n\n          -  Uterine contractions of at least 1 in 10 minutes over 1 hour\n\n          -  Cervical dilation between 2 cm and 4 cm inclusive\n\n        Exclusion Criteria:\n\n          -  Multifetal gestation\n\n          -  Less than 28 weeks' gestation\n\n          -  34 or more weeks' gestation\n\n          -  Ruptured membranes\n\n          -  More than 4 cm dilated\n\n          -  Corticosteroids contraindicated per Parkland Hospital protocol\n\n          -  Previously received a course of corticosteroids for fetal lung maturation\n\n          -  Oligohydramnios\n\n          -  Fetal growth restriction\n\n          -  Chorioamnionitis or temperature of at least 38.0 degrees Celsius\n\n          -  Fetal death\n\n          -  Preeclampsia\n\n          -  Suspected placental abruption or placenta previa\n\n          -  Systolic BP < 90 mmHg or diastolic BP < 50 mmHg\n\n          -  Baseline tachycardia (pulse >120 after 2 consecutive measurements 30 minutes apart)\n\n          -  Chronic hypertension treated with antihypertensives in pregnancy\n\n          -  Seizure disorder or HIV\n\n          -  Maternal allergy to nifedipine\n\n          -  Known maternal cardiac disease"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "44 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02132533", 
            "org_study_id": "122013-063"
        }, 
        "intervention": [
            {
                "arm_group_label": "Nifedipine", 
                "description": "Nifedipine 20 mg orally, then nifedipine 20 mg orally after 90 minutes if still contracting. Continue nifedipine 20 mg orally every 4 hours after the first dose for 48 hours.", 
                "intervention_name": "Nifedipine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo orally, then placebo orally after 90 minutes if still contracting. Continue placebo orally every 4 hours after the first dose for 48 hours.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Nifedipine", 
                    "Placebo"
                ], 
                "description": "Usual evaluation, monitoring and care for women with preterm labor.", 
                "intervention_name": "Usual care", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Nifedipine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Dallas", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "75390"
                }, 
                "name": "Parkland Memorial Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Josiah S Hawkins, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Brian M Casey, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Kenneth J Leveno, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Nifedipine for Acute Tocolysis of Preterm Labor", 
        "overall_contact": {
            "email": "josiah.hawkins@utsouthwestern.edu", 
            "last_name": "Josiah S Hawkins, MD", 
            "phone": "214-648-4746"
        }, 
        "overall_contact_backup": {
            "email": "brian.casey@utsouthwestern.edu", 
            "last_name": "Brian M Casey, MD", 
            "phone": "214-648-4746"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Texas Southwestern Medical Center", 
                "last_name": "Josiah S Hawkins, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Texas Southwestern Medical Center", 
                "last_name": "Brian M Casey, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "University of Texas Southwestern Medical Center", 
                "last_name": "Donald D McIntire, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "University of Texas Southwestern Medical Center", 
                "last_name": "Kenneth J Leveno, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Percentage of women with preterm birth at less than 37 weeks of gestation", 
            "safety_issue": "No", 
            "time_frame": "Within 24 hours after delivery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02132533"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Percentage of women with preterm birth within 48 hours of randomization", 
                "safety_issue": "No", 
                "time_frame": "Within 24 hours after delivery"
            }, 
            {
                "measure": "Percentage of women with at least 2 doses of betamethasone administered prior to delivery", 
                "safety_issue": "No", 
                "time_frame": "Within 24 hours after delivery"
            }, 
            {
                "measure": "Percentage of women with preterm birth within 7 days of randomization", 
                "safety_issue": "No", 
                "time_frame": "Within 24 hours after delivery"
            }
        ], 
        "source": "University of Texas Southwestern Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Texas Southwestern Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}